Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBorg, Brigitte M-
dc.contributor.authorOsadnik, Christian-
dc.contributor.authorAdam, Keith-
dc.contributor.authorChapman, David G-
dc.contributor.authorFarrow, Catherine E-
dc.contributor.authorGlavas, Vanda-
dc.contributor.authorHancock, Kerry-
dc.contributor.authorLanteri, Celia J-
dc.contributor.authorMorris, Ewan G-
dc.contributor.authorRomeo, Nicholas-
dc.contributor.authorSchneider-Futschik, Elena K-
dc.contributor.authorSelvadurai, Hiran-
dc.identifier.citationRespirology (Carlton, Vic.) 2022; 27(9): 688-719en
dc.description.abstractThe Thoracic Society of Australia and New Zealand (TSANZ) and the Australian and New Zealand Society of Respiratory Science (ANZSRS) commissioned a joint position paper on pulmonary function testing during coronavirus disease 2019 (COVID-19) in July 2021. A working group was formed via an expression of interest to members of both organizations and commenced work in September 2021. A rapid review of the literature was undertaken, with a 'best evidence synthesis' approach taken to answer the research questions formed. This allowed the working group to accept findings of prior relevant reviews or societal document where appropriate. The advice provided is for providers of pulmonary function tests across all settings. The advice is intended to supplement local infection prevention and state, territory or national directives. The working group's key messages reflect a precautionary approach to protect the safety of both healthcare workers (HCWs) and patients in a rapidly changing environment. The decision on strategies employed may vary depending on local transmission and practice environment. The advice is likely to require review as evidence grows and the COVID-19 pandemic evolves. While this position statement was contextualized specifically to the COVID-19 pandemic, the working group strongly advocates that any changes to clinical/laboratory practice, made in the interest of optimizing the safety and well-being of HCWs and patients involved in pulmonary function testing, are carefully considered in light of their potential for ongoing use to reduce transmission of other droplet and/or aerosol borne diseases.en
dc.subjectpersonal protective equipmenten
dc.subjectpulmonary function testsen
dc.subjectrespiratory function testsen
dc.titlePulmonary function testing during SARS-CoV-2: An ANZSRS/TSANZ position statement.en
dc.typeJournal Articleen
dc.identifier.journaltitleRespirology (Carlton, Vic.)en
dc.identifier.affiliationWestmead Clinical School, Sydney Medical School, Faculty of Medicine and Health Sciences, The University of Sydney, Sydney, New South Wales, Australia..en
dc.identifier.affiliationMonash Lung Sleep Allergy & Immunology, Monash Health, Clayton, Victoria, Australia..en
dc.identifier.affiliationSonic HealthPlus, Osborne Park, Western Australia, Australia..en
dc.identifier.affiliationRespiratory Investigation Unit, Department of Respiratory Medicine, Royal North Shore Hospital, St Leonards, New South Wales, Australia..en
dc.identifier.affiliationAirway Physiology & Imaging Group, Woolcock Institute of Medical Research, The University of Sydney, Glebe, New South Wales, Australia..en
dc.identifier.affiliationDiscipline of Medical Science, School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, New South Wales, Australia..en
dc.identifier.affiliationRespiratory Function Laboratory, Department of Respiratory and Sleep Medicine, Westmead Hospital, Westmead, New South Wales, Australia..en
dc.identifier.affiliationDepartment of Respiratory Medicine, The Children's Hospital, Westmead, Sydney Childrens Hospital Network, Sydney, NSW, Australia..en
dc.identifier.affiliationDiscipline of Child and Adolescent Health, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia..en
dc.identifier.affiliationRespiratory SA, Kent Town, South Australia, Australia..en
dc.identifier.affiliationChandlers Hill Surgery, Happy Valley, South Australia, Australia..en
dc.identifier.affiliationRespiratory and Sleep Medicineen
dc.identifier.affiliationInstitute for Breathing and Sleepen
dc.identifier.affiliationDepartment of Respiratory Medicine, Northern Health, Epping, Victoria, Australia..en
dc.identifier.affiliationCystic Fibrosis Pharmacology Laboratory, Department of Biochemistry & Pharmacology, University of Melbourne, Parkville, Victoria, Australia..en
dc.identifier.affiliationSchool of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, Victoria, Australia..en
dc.identifier.affiliationRespiratory Medicine, The Alfred, Melbourne, Victoria, Australia..en
dc.identifier.affiliationSchool of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia..en
dc.identifier.affiliationDepartment of Physiotherapy, Monash University, Frankston, Victoria, Australia..en
dc.identifier.affiliationDepartment of Respiratory Medicine, Waitematā District Health Board, Auckland, New Zealand..en
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

checked on Sep 26, 2023

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.